Establishment of a binational cohort to study Helicobacter pylori infection in children

Karen J Goodman1, Kathleen O'Rourke, R Sue Day

  • 1School of Public Health, University of Texas-Houston Health Science Center, Houston, Texas 77225, USA. kgoodman@sph.uth.tmc.edu

Ethnicity & Disease
|August 5, 2003
PubMed

Insights

This study followed children in the US-Mexico border region to understand chronic Helicobacter pylori infection. Findings aim to identify risk factors and develop prevention strategies for this common childhood infection.

Area of Science:

  • Pediatric infectious diseases
  • Gastroenterology
  • Epidemiology

Background:

  • Chronic Helicobacter pylori infection, often starting in childhood, significantly impacts marginalized populations.
  • This infection is prevalent among ethnic minority and immigrant children in the United States, particularly those of Mexican origin.
  • Current prevention strategies are limited due to insufficient understanding of infection causes.

Purpose of the Study:

  • To investigate the natural history of H. pylori infection in children.
  • To identify risk factors associated with H. pylori acquisition, recurrence, and persistence.
  • To establish a cohort for ongoing research on H. pylori epidemiology in a unique border population.

Main Methods:

  • The Pasitos Cohort Study enrolled children from low-income families in the El Paso, Texas, and Ciudad Juarez, Chihuahua border region.
  • Pregnant women were screened, and eligible participants were enrolled prior to their child's birth.
  • Infants were followed at 6-month intervals to monitor H. pylori infection and related factors.

Main Results:

  • Between April 1998 and October 2000, 1,288 pregnant women were screened, with 807 eligible women consenting.
  • Birth documentation was obtained for 615 infants, and 472 successfully entered the follow-up phase.
  • The study highlights challenges in maintaining long-term participant compliance in the border setting.

Conclusions:

  • Establishing and maintaining a pediatric cohort in a border region presents unique logistical and resource challenges.
  • Long-term follow-up requires dedicated staff and participant incentives.
  • Future findings are expected to significantly advance knowledge on H. pylori epidemiology and inform prevention strategies.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...